Travel Briefing: One In Seven Crashes Now Ends With A Hit-And-Run Driver Strategic angle: New crash data from AAA shows hit-and-run incidents rising across the U.S., raising serious safety concerns. Editorial Staff Mar 15
Life Briefing: Starcloud files plans for 88,000-satellite constellation Strategic angle: An orbital data center startup is seeking approval from the Federal Communications Commission for a constellation of as many as 88,000 satellites. Editorial Staff Mar 15
Life Briefing: Pesticides from flea treatments and sheep dips found at damaging levels in Welsh rivers Strategic angle: New research reveals alarming levels of pesticides in Welsh rivers, posing potential environmental risks. Editorial Staff Mar 15
Sports Briefing: Lakers benefitted from incorrect foul call in final seconds of regulation in comeback over Nuggets, NBA says Strategic angle: Austin Reaves shouldn't have gone to the free-throw line with 9.2 seconds remaining. Editorial Staff Mar 15
Money Briefing: Why Trump Wants Greenland So Badly—What's Under The Ice Could Explain It Strategic angle: Exploring the economic motivations behind Trump's interest in Greenland. Editorial Staff Mar 15
Money Briefing: Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen Strategic angle: Industry experts predict escalating challenges in energy supply under current administration policies. Editorial Staff Mar 15
Money Briefing: Viking Holdings (VIK) Announces Taking Delivery of its Newest River Cruise Ship Strategic angle: Viking Holdings expands its fleet with the latest addition to its river cruise offerings. Editorial Staff Mar 15
Sports Briefing: 2026 NFL Free Agency Tracker: Updates on Top 100 Free Agents, Including Kyler Murray Signing with Vikings Strategic angle: A running tracker of all the big free agent deals and player movement. Editorial Staff Mar 15
Money Briefing: This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss Strategic angle: Merck & Co. is taking strategic steps to address the impending loss of exclusivity for KEYTRUDA. Editorial Staff Mar 15
Money Briefing: Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India Strategic angle: Abbott Laboratories introduces a new product aimed at improving cardiovascular care in the Indian market. Editorial Staff Mar 15